Missense and nonsense mutations in the glucokinase gene have recently been shown to result in maturity-onset diabetes of the young (MODY), a subtype of non-insulin-dependent diabetes mellitus with early age of onset. Glucokinase catalyzes the formation of glucose-6-phosphate and is involved in the regulation of insulin secretion and integration of hepatic intermediary metabolism. Nucleotide sequence analysis of exon 4 and its flanking intronic regions of the glucokinase gene, in four hyperglycemic individuals of a MODY family, revealed a deletion of 15 base pairs, which removed the t of the gt in the donor splice site of intron 4, and the following 14 base pairs. This deletion resulted in two aberrant transcripts, which were analyzed by reverse transcription of RNA from lymphoblastoid cells obtained from a diabetic patient. In one of the abnormal transcripts, exon 5 is missing, while in the other, the activation of a cryptic splice site leads to the removal of the last eight codons of exon 4. This intronic deletion in a donor splice site seems to cause a more severe form of glucose intolerance, compared with point mutations described in glucokinase. This might be due to a more pronounced effect on insulin secretion.
F Sun, B Knebelmann, M E Pueyo, H Zouali, S Lesage, M Vaxillaire, P Passa, D Cohen, G Velho, C Antignac
Title and authors | Publication | Year |
---|---|---|
Glucokinase (GCK) in diabetes: from molecular mechanisms to disease pathogenesis
Abu Aqel Y, Alnesf A, Aigha II, Islam Z, Kolatkar PR, Teo A, Abdelalim EM |
Cellular & Molecular Biology Letters | 2024 |
Evaluation in Monogenic Diabetes of the Impact of GCK, HNF1A, and HNF4A Variants on Splicing through the Combined Use of In Silico Tools and Minigene Assays
Bouvet D, Blondel A, de Sainte Agathe JM, Leroy G, Saint-Martin C, Bellanné-Chantelot C |
Human Mutation | 2023 |
Mutations in exons 10 and 11 of human glucokinase result in conformational variations in the active site of the structure contributing to poor substrate binding – explains hyperglycemia in type 2 diabetic patients
N Yellapu, MK Mahto, KR Valasani, PV Sarma, B Matcha |
Journal of Biomolecular Structure and Dynamics | 2014 |
Identification and analysis of novel R308K mutation in glucokinase of type 2 diabetic patient and its kinetic correlation: Identification and Analysis of R308K Mutation in GK
NK Yellapu, KR Valasani, SK Pasupuleti, S Gopal, SP Krishna, B Matcha |
Biotechnology and Applied Biochemistry | 2014 |
Acetylcholinesterase Inhibitors: Structure Based Design, Synthesis, Pharmacophore Modeling and Virtual Screening
KR Valasani, MO Chaney, VW Day, SS Yan |
Journal of Chemical Information and Modeling | 2013 |
A novel synonymous substitution in the GCK gene causes aberrant splicing in an Italian patient with GCK-MODY phenotype
S Costantini, P Prandini, M Corradi, A Pasquali, G Contreas, PF Pignatti, L Pinelli, E Trabetti, C Maffeis |
Diabetes Research and Clinical Practice | 2011 |
Best practice guidelines for the molecular genetic diagnosis of maturity-onset diabetes of the young.
Ellard S, Bellanné-Chantelot C, Hattersley AT |
Diabetologia | 2008 |
Abnormal splicing of hepatocyte nuclear factor-1 beta in the renal cysts and diabetes syndrome
AT Hattersley, C Bingham, LW Harries, S Ellard, RW Jones |
Diabetologia | 2004 |
Intrinsic differences between authentic and cryptic 5' splice sites
X Roca, R Sachidanandam, AR Krainer |
Nucleic Acids Research | 2003 |
Molecular Basis of Pancreas Development and Function
JF Habener, MA Hussain |
2001 | |
Information analysis of human splice site mutations
PK Rogan, BM Faux, TD Schneider |
Human Mutation | 1998 |
NON–INSULIN-DEPENDENT DIABETES MELLITUS IN CHILDHOOD AND ADOLESCENCE
NS Glaser |
Pediatric Clinics of North America | 1997 |
Interleukin-1 Reduces the Glycolytic Utilization of Glucose by Pancreatic Islets and Reduces Glucokinase mRNA Content and Protein Synthesis by a Nitric Oxide-dependent Mechanism
Z Ma, M Landt, A Bohrer, S Ramanadham, DM Kipnis, J Turk |
The Journal of biological chemistry | 1997 |
Studies of the Impact of a Liver Glucokinase Promoter Variant on Glucose Tolerance and Insulin Sensitivity Index1
SA Urhammer, T Hansen, LB Jensen, JO Clausen, L Hansen, KC Chui, O Pedersen |
The Journal of clinical endocrinology and metabolism | 1997 |
Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects
G Velho, KF Petersen, G Perseghin, JH Hwang, DL Rothman, ME Pueyo, GW Cline, P Froguel, GI Shulman |
Journal of Clinical Investigation | 1996 |
GENETICS OF NON-INSULIN-DEPENDENT (TYPE-II) DIABETES MELLITUS
CR M.D, DV M.D, AD Ph.D |
Annual Review of Medicine | 1996 |
Comprehensive Human Physiology
R Greger, U Windhorst |
1996 | |
Assessment of insulin sensitivity in glucokinase-deficient subjects
K Clément, M E Pueyo, M Vaxillaire, B Rakotoambinina, F Thuillier, P Passa, P Froguel, J J Robert, G Velho |
Diabetologia | 1996 |
Transgenic knockouts reveal a critical requirement for pancreatic β cell glucokinase in maintaining glucose homeostasis
A Grupe, B Hultgren, A Ryan, YH Ma, M Bauer, TA Stewart |
Cell | 1995 |
Germ-line p53 mutations in 15 families with Li-Fraumeni syndrome
T Frebourg, N Barbier, YX Yan, JE Garber, M Dreyfus, J Fraumeni, FP Li, SH Friend |
The American Journal of Human Genetics | 1995 |
Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny
C Postic, M Shiota, KD Niswender, TL Jetton, Y Chen, JM Moates, KD Shelton, J Lindner, AD Cherrington, MA Magnuson |
Development (Cambridge, England) | 1995 |
The genetics of non-insulin-dependent diabetes mellitus: tools and aims
MI McCarthy, P Froguel, GA Hitman |
Diabetologia | 1994 |
Maturity-onset diabetes of the young
SS Fajans, GI Bell, DW Bowden, JB Halter, KS Polonsky |
Life Sciences | 1994 |
Genetic factors in coronary heart disease
U Goldbourt, U de Faire, K Berg |
1994 |